Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Statement of Cash Flows [Abstract]
Net Loss			$ (3,603,627)	$ (3,648,719)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation			1,844	683
Stock based compensation			122,656	110,115
Amortization of debt issuance costs			87,011	4,862
Non-cash interest expense			766,668	312,875
Accretion expense	$ 45,619	$ 110,558	134,174	221,117	$ 442,234
Settlement of asset retirement obligations			(60,000)	(60,000)
Change in derivative liability	400,144		164,055
Effect of changes in operating working capital items:
Change in prepaid expenses			540,128	660,825
Change in accounts payable			(215,698)	871,223
Cash used in operating activities			(2,062,789)	(1,527,019)
Cash flows from investing activities:
Purchase of mineral properties			(50,000)	(50,000)
Purchase of equipment			(9,098)
Cash used in investing activities			(59,098)	(50,000)
Cash flows from financing activities:
Capital issued for financing, net of share issuance costs			104,228	1,140,652
Proceeds from royalty convertible debenture				15,000,000
Royalty convertible debenture issuance costs				(870,111)
Repayment of 2019 convertible notes				(4,277,690)
Repayment of notes payable, related parties				(1,667,833)
Cash provided by financing activities			104,228	9,325,018
Change in cash during period			(2,017,659)	7,747,999
Cash at beginning of period			5,423,059	824,920	824,920
Cash at end of period	$ 3,405,400	$ 8,572,919	$ 3,405,400	$ 8,572,919	$ 5,423,059